Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can sensing wrist position unlock better hand control in MS?

NCT ID NCT06232850

Knowledge-focused Sponsor: Pamukkale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study investigates whether the ability to sense wrist position is linked to manual dexterity in people with multiple sclerosis (MS). Researchers will measure wrist position sense using a special device and assess hand skills with a pegboard test. The goal is to understand how these factors relate, which could inform future rehabilitation approaches. Participants include people with relapsing-remitting MS and healthy volunteers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If a link is found, it could point toward new rehabilitation strategies for improving hand function in MS.
What could go wrong
This is a small observational study, so it may not reveal a clear connection or lead to immediate treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

48 people

The number who actually took part.

Started

Jan 2024

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

MS and healthy individuals who proper the inclusion and exclusion criteria

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient group: * Disability score (EDSS: Expanded Disability Status Scale) should be between 0-3. * Being between the ages of 18-50 * Not having had an attack in the last 3 months * Scoring 24 points or above on the Mini-Mental State Examination * Patients diagnosed with relapsing-remitting MS with a disease duration of at least 2 years * Patients without spasticity according to MAS Control group: * Volunteers in a similar age range who agreed to participate in the study * Being between the ages of 18-50 Exclusion Criteria: * Patient group: * Presence of diagnosed visual impairment * Having other chronic diseases not related to MS * Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement * History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function * Presence of wrist joint range of motion limitation Control group: * Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement * History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function * Presence of wrist joint range of motion limitation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Müge içelli güneş

    Denizli, Deni̇zli̇, 20160, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.